Showing results (2611-2620 of 6,717) with videos related to
Sort By:
Pageof 672
Oncotargets and Therapy|December 26, 2013
Primary malignant fibrous histiocytoma of the renal pelvis: a 78-month follow-up case reportYuebing Chen, Dapang Rao, Haibo Zhu, et al.Oncotargets and Therapy|August 27, 2015
A polymorphism at the microRNA binding site in the 3' untranslated region of RYR3 is associated with outcome in hepatocellular carcinomaChenxing Peng, Zhanjun Guo, Xiaoyan Wu, et al.Oncotargets and Therapy|March 9, 2016
Neoadjuvant chemoradiotherapy or chemotherapy followed by surgery is superior to that followed by definitive chemoradiation or radiotherapy in stage IIIA (N2) nonsmall-cell lung cancer: a meta-analysis and system reviewXiao-Ling Xu, Li Dan, Wei Chen, et al.Oncotargets and Therapy|August 12, 2015
Low claudin-6 expression correlates with poor prognosis in patients with non-small cell lung cancerQiang Wang, Yan Zhang, Tao Zhang, et al.Oncotargets and Therapy|February 6, 2016
Single sternal metastasis due to malignant melanoma with unexpected long-term survival: a case reportApostolos S Gogakos, Dimitrios Paliouras, Christos Asteriou, et al.Oncotargets and Therapy|February 9, 2016
MicroRNA-497 inhibits cell proliferation, migration, and invasion by targeting AMOT in human osteosarcoma cellsWen-Dong Ruan, Pei Wang, Shiqing Feng, et al.Oncotargets and Therapy|February 9, 2016
Cost-effectiveness of radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancerYanlan Chai, Juan Wang, Tao Wang, et al.Oncotargets and Therapy|February 9, 2016
Association between the Cyclin D1 G870A polymorphism and the susceptibility to and prognosis of upper aerodigestive tract squamous cell carcinomas: an updated meta-analysisYichen Meng, Chenglin Zhang, Xuhui ZhouOncotargets and Therapy|February 9, 2016
New developments in the management of chronic lymphocytic leukemia: role of ofatumumabLuca Laurenti, Idanna Innocenti, Francesco Autore, et al.Oncotargets and Therapy|February 9, 2016
Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosisHanxiao Xu, Yijun Tian, Xun Yuan, et al.Pageof 672